Less Ads, More Data, More Tools Register for FREE

Pin to quick picksS & U Regulatory News (SUS)

Share Price Information for S & U (SUS)

Share Price is delayed by 15 minutes
Get Live Data
1,980.00    10.00 (0.51%)
Bid:
1,940.00
Ask:
1,990.00
Spread: 50.00 (2.577%)
Market Cap: £240.59m
SUS Live PriceLast checked at - London Stock Exchange

Intraday S & U Share Chart

CORRECTION: TRADING STATEMENT & NOTICE OF RESULTS

11 Feb 2021 10:00

RNS Number : 7985O
S & U PLC
11 February 2021
 

Correction: Further to RNS number 6787O released earlier today, the interim ordinary share dividend will be paid to those shareholders on the register on Friday 19th February 2021 and not 20th February 2021. This has been corrected in the statement below. All other details remain unchanged.

 

 

11 February 2021

 

S&U plc

("S&U" or "the Group")

 

CORRECTION: TRADING STATEMENT AND NOTICE OF RESULTS

 

S&U plc, the specialist motor finance and property bridging lender, today issues a trading update for the period from its trading statement of 9 December 2020 to the Group's year end on 31 January 2021. The Group's full year results will be announced on 30 March 2021.

 

The Group's trading remains robust and profitable, despite the current lockdown and the induced coma into which the Government has needed to place the wider UK economy. Demand by customers in both divisions remains strong and collections quality continues to be good.

 

We are planning for a significant rebound to pre-Covid motor finance transaction levels as lockdown restrictions ease this year, and a substantial increase in business at Aspen our property bridging business.

 

Motor Finance

Transaction numbers at Advantage have held up well over the period and, despite the closure of a number of car showrooms, continue to improve. In the past 2 months new deal transactions have reached nearly 80% of the comparable period last year and rising. Record application numbers continue, although Advantage's prudently responsible underwriting and affordability requirements have seen new deal transactions for the year as a whole total around 15,600 with customer numbers at year end of just under 63,000 and net receivables of around £247m.

 

Advantage's industry leading customer analysis and an evolving product range present tremendous opportunity for growth throughout the non-prime finance spectrum, despite the more competitive environment.

 

Repayment quality remains good; Advantage's collections department has always been proud of the sustainable relationships it develops with customers. Thus, the number of customers remaining on payment holiday has reduced from 15,000 at the peak to below 4,000. These relationships are also reflected in their payment performance, and in January monthly collections improved to 90% of contractual terms due.

 

More important, despite an increase in covid cases in the first half of the period under review Advantage is keeping staff safe. Moreover, our continuous drive for improvement has seen the launch of initiatives on affiliate introducers, product development and customer service - the latter reflected in Advantage's latest Trustpilot consumer ratings of 4.8 out of 5.0.

 

Aspen Bridging

Aspen continues to make great progress both in terms of growth and quality. In a resilient residential housing market, (Zoopla's UK house price index recently reported year on year growth of 5.9%), Aspen has seen net receivables rise from £29.6m to around £34m in the period. During this time, new transactions have consistently beaten budget, and Aspen's deal pipeline has more than doubled.

 

Experience, market credibility and sensible underwriting have seen credit quality at its best ever, with only three of over sixty customers slightly beyond term at year end. These promising trends have justified a further £4m investment in Aspen over the past two months, and the recruitment of experienced new staff in business development and underwriting.

 

Funding

S&U's financial position has been strengthened still further as borrowings have fallen to £99m from £103m. Gearing now stands at approximately 55% from 58%. This reflects continued and seasonal cash generation at Advantage, offset by additional investment in Aspen. £130m of Group facilities provide significant headroom for growth.

 

Dividend

Despite the inevitable effect of Covid-19 on S&U's profitability, our confidence in future trading, our financial strength and consistent commitment to shareholder reward justify a second interim dividend this year of 25p per ordinary share (2020: 36p). This will be paid on 12th March 2021 to those shareholders on the register on the 19th February 2021.

 

 

Commenting on the Group's performance and outlook, Anthony Coombs, S&U Chairman, said:

 

"Although the return to economic and general health in the UK will be uneven, the outlook is undoubtedly brightening. The proven strength and experience of S&U, exemplified by our loyal and dedicated staff, make me confident that we can grasp the tremendous opportunities economic revival will bring."

 

 

For further information, please contact:

 

S&U

Anthony Coombs, Chairman 0121 705 7777

 

Newgate Communications

Bob Huxford, Megan Kovak, Tom Carnegie 020 7653 9848

 

Peel Hunt

Adrian Trimmings, Andrew Buchanan, Rishi Shah 020 7418 8900

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTGPUQCPUPGUBG
Date   Source Headline
8th Mar 20139:32 amRNSNotice of Results
8th Feb 20137:00 amRNSTrading Statement
1st Feb 20134:00 pmRNSPurchase of Own Shares
6th Dec 20127:00 amRNSInterim Management Statement
1st Nov 20123:40 pmRNSDirector/PDMR Shareholding
4th Oct 20127:00 amRNSDirector/PDMR Shareholding
3rd Oct 201212:48 pmRNSDirector/PDMR Shareholding
26th Sep 20127:00 amRNSHalf Yearly Report
8th Aug 20127:00 amRNSTrading Statement
21st Jun 201210:07 amRNSDirector/PDMR Shareholding
13th Jun 20125:17 pmRNSDirector/PDMR Shareholding
29th May 20127:00 amRNSDTR 5.6.1 and Director/PDMR Shareholding
25th May 20125:15 pmRNSDirector/PDMR Shareholding - correction
25th May 20124:32 pmRNSDirector/PDMR Shareholding
24th May 201212:43 pmRNSAGM Statement
24th May 20127:00 amRNSInterim Management Statement
17th May 20124:14 pmRNSDirector/PDMR Shareholding
4th May 201211:07 amRNSDirector/PDMR Shareholding
17th Apr 20127:00 amRNSAnnual Financial Report
30th Mar 20122:48 pmRNSAnnual Information Update
29th Mar 20124:36 pmRNSFinal Results: Correction to dividend dates
29th Mar 20127:00 amRNSFinal Results
17th Feb 20127:00 amRNSTrading Statement
9th Dec 20117:00 amRNSInterim Management Statement
25th Nov 20117:00 amRNSDirector/PDMR Shareholding
3rd Nov 20118:57 amRNSDirector/PDMR Shareholding
3rd Oct 20114:32 pmRNSDirector/PDMR Shareholding
22nd Sep 20117:00 amRNSHalf Yearly Report
19th Aug 20113:23 pmRNSDirector/PDMR Shareholding
10th Aug 20117:00 amRNSTrading Statement
15th Jul 20114:32 pmRNSDirector/PDMR Shareholding
5th Jul 20114:52 pmRNSNotification of Major Interest in Shares
27th May 20117:00 amRNSDirector/PDMR Shareholding
13th May 201112:15 pmRNSAGM Statement and Consultation re Move to AIM
13th May 20117:00 amRNSInterim Management Statement
11th Apr 20117:00 amRNSAnnual Financial Report
8th Apr 20114:00 pmRNSDirector/PDMR Shareholding
1st Apr 20117:00 amRNSAnnual Information Update
30th Mar 20117:00 amRNSDirector/PDMR Shareholding
23rd Mar 20117:01 amRNSDirectorate Change
23rd Mar 20117:00 amRNSFinal Results
11th Feb 20117:00 amRNSTrading Statement
10th Dec 20107:00 amRNSInterim Management Statement
8th Oct 20101:30 pmRNSDirector/PDMR Shareholding
24th Sep 20104:41 pmRNSDirector/PDMR Shareholding
23rd Sep 20107:00 amRNSHalf Yearly Report
31st Aug 20107:01 amRNSChange of Adviser
11th Aug 20107:00 amRNSTrading Statement
18th Jun 20102:45 pmRNSDirector/PDMR Shareholding
4th Jun 20105:03 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.